bodalal
عضو مبدع
- التسجيل
- 25 أبريل 2005
- المشاركات
- 394
السلام عليكم ..
هذي توصية من منتدى 3StocksonFire مو مني ..
وهي لشركة أدوية صينية تم إجازة أحد أدويتها المهمة ( دواء لمرض سارس الله يبعده عنا جميعا ) مؤخراً من قبل FDA الصينية
وهذا هو مختصر الخبر في الياهو
رابط الخبر : http://biz.yahoo.com/bw/050727/275400.html?.v=1
ويبدو أنها ستقفز في القريب العاجل ... بحسب ما قرأت في المنتدى
===================
Sinovac Biotech, Ltd (SVA), specializes in the research, development, commercialization, and sale of human vaccines for infectious illnesses, such as Hepatitis A and Hepatitis B, influenza, and SARS in China and internationally. The company has three vaccines that have completed three phases of clinical trials: Hepatitis A, Hepatitis A&B combined, and influenza (flu).
We've had this important news a few days ago: Sinovac Biotech Ltd. Receives Flu Vaccine Production License from Chinese FDA
The market cap is just about $140M.
We have a company already producing 2 vaccines for the Chinese market and with another powerful one approved. I see plenty of room for speculation here. I can say SVA is exactly the kind of stock that I want now.
Looking at the long term chart we find that SVA has recently broken a long term descending trendline, so the market is recognizing the value of this company:
منقول
===================
يا ليت خبراء التحليل يفيدونا برايهم
وعسى الله يرزق الجميع
هذي توصية من منتدى 3StocksonFire مو مني ..
وهي لشركة أدوية صينية تم إجازة أحد أدويتها المهمة ( دواء لمرض سارس الله يبعده عنا جميعا ) مؤخراً من قبل FDA الصينية
وهذا هو مختصر الخبر في الياهو
رابط الخبر : http://biz.yahoo.com/bw/050727/275400.html?.v=1
ويبدو أنها ستقفز في القريب العاجل ... بحسب ما قرأت في المنتدى
===================
Sinovac Biotech, Ltd (SVA), specializes in the research, development, commercialization, and sale of human vaccines for infectious illnesses, such as Hepatitis A and Hepatitis B, influenza, and SARS in China and internationally. The company has three vaccines that have completed three phases of clinical trials: Hepatitis A, Hepatitis A&B combined, and influenza (flu).
We've had this important news a few days ago: Sinovac Biotech Ltd. Receives Flu Vaccine Production License from Chinese FDA
The market cap is just about $140M.
We have a company already producing 2 vaccines for the Chinese market and with another powerful one approved. I see plenty of room for speculation here. I can say SVA is exactly the kind of stock that I want now.
Looking at the long term chart we find that SVA has recently broken a long term descending trendline, so the market is recognizing the value of this company:
منقول
===================
يا ليت خبراء التحليل يفيدونا برايهم
وعسى الله يرزق الجميع
